Initiation Archives - Page 145 of 272

SVB Leerink analyst Thomas Smith initiates coverage on Alpine Immune Sciences (NASDAQ:ALPN) with a Outperform rating and announces Price Target of $16.

ALPN

1 minute read

BTIG Initiates Coverage On Cullinan Oncology with Buy Rating, Announces Price Target of $20

By Benzinga Newsdesk

November 21, 7:31 AM

BTIG analyst Kaveri Pohlman initiates coverage on Cullinan Oncology (NASDAQ:CGEM) with a Buy rating and announces Price Target of $20.

CGEM

1 minute read

Goldman Sachs Initiates Coverage On Mobileye Global with Buy Rating, Announces Price Target of $36

By Benzinga Newsdesk

November 21, 7:27 AM

Goldman Sachs analyst Mark Delaney initiates coverage on Mobileye Global (NASDAQ:MBLY) with a Buy rating and announces Price Target of $36.

MBLY

1 minute read

Piper Sandler Initiates Coverage On Cue Biopharma with Overweight Rating, Announces Price Target of $7

By Benzinga Newsdesk

November 21, 6:07 AM

Piper Sandler analyst Edward Tenthoff initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Overweight rating and announces Price Target of $7.

CUE

1 minute read

Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding

By Vandana Singh

November 18, 4:00 PM

Credit Suisse has initiated coverage on Pfizer Inc (NYSE:PFE) with an Outperform rating and a price target of $55. The analyst…

PFE

1 minute read

Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock

By Vandana Singh

November 18, 3:54 PM

Credit Suisse has initiated coverage on Johnson & Johnson (NYSE:JNJ) with a Neutral rating and a price target of $170. The…

JNJ